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Abstract
Objective: This study aims to investigate the time pattern of inconsistence condom use (ICU) during the first year of
antiretroviral therapy (ART) and its relationship with treatment adherence in naı ¨ve HIV-infected adult patients.
Methods: Data collection was nested within a longitudinal trial on HIV treatment. ICU was defined as reporting to have
‘‘never’’, ‘‘sometimes’’ or ‘‘nearly always’’ used condoms with one’s main or casual partner(s) - either HIV-negative or of
unknown HIV status in the three previous months. Adherence was defined as taking 100% of their ART prescribed doses in
the 4 days before the visit and ‘‘not having interrupted treatment’’, even once, for more than two consecutive days during
the 4 previous weeks. Mixed logistic regression was used to study the relationship between adherence and ICU.
Results: Among the 459 patients enrolled, 212 (46%) during 334 visits reported to have had sexual intercourse at least once
with their partner(s) – either HIV-negative or of unknown HIV status- during the first 12 months of ART. The proportion of
ICU was 76%, 50% and 59% at month 0 (M0), month 6 (M6) and month 12 (M12), while 60% and 66% of patients were ART-
adherent at M6 and M12, respectively. After adjustment for the frequency of sexual activity, type of sexual partner(s),
perceived social class and desire for a child, patients adherent to ART were less likely to report ICU when compared with
baseline (AOR [95% CI]: 0.38 [0.19–0.76]; P=0.006).
Conclusions: Adherence to ART is associated with a lower risk of ICU but this result needs to be interpreted carefully. As
adherence behaviors are not only determined by problems with the healthcare systems but also by social barriers
encountered by patients in their daily life, counseling should not only be ART adherence-centered but also patient-
centered, including sexual risk minimization and psychosocial support.
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Introduction
Since the introduction of the WHO ‘‘3 by 5’’ initiative [1],
access to and use of health services providing antiretroviral therapy
(ART) by people living with HIV/AIDS (PLWHA) in Sub-
Saharan Africa has increased rapidly and substantially. However
this progress in ART coverage remains concomitant with a high
incidence of HIV infection, highlighting the need for substantially
greater success in the prevention of new HIV infections [2]. While
ART is increasingly regarded as a preventive intervention able to
significantly reduce sexual transmission of HIV through decreased
viremia [3,4], sexual behaviors among PLWHA on ART remain a
topic of major interest in Sub-Saharan Africa where the great
majority of infections are attributable to sexual transmission [5].
On the one hand, several studies have confirmed that sustained
adherence and continuity of ART - the basic conditions for
treatment as prevention (TasP) [4] - remain a major challenge in
Sub-Saharan countries where access to treatment is constrained by
economic and structural barriers [6]. On the other hand, results of
meta-analyses conducted both in high- and low-resource settings
[7,8] concluded that while ART-treated patients do not exhibit
increased sexual risk behaviors, unprotected sex remains highly
prevalent in Sub-Saharan African patients [8,9,10], including
viremic patients, something also suggested by a study of Wandera
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 et al. [10]. Few studies however have used longitudinal data to
describe sexual behaviors during the course of ART or to assess
the temporal relationship between psychosocial factors such as
ART adherence and sexual behaviors. The relationship between
ART adherence and unsafe sexual behaviors is of particular
interest as the former may be considered a major component of
the well-known ‘‘Swiss statement’’ which claims that there is a
reduced likelihood of HIV sexual transmission in patients with a
history of adherence and controlled viremia [4].
This analysis, based on longitudinal data of HIV-infected adults
enrolled in the Stratall ANRS 12110/ESTHER trial in Camer-
oon, was designed to study the time pattern of unsafe sexual
behaviors during the first 12 months of ART and its relationship
with treatment adherence. However, as the study is focused on
predictors of positive prevention (and not on unsafe sexual
behaviors per se) we preferred to target individuals who had
behaviors leading to a higher risk of HIV transmission– i.e.,
individuals with partners who were seronegative or whose
serostatus was unknown.
Materials and Methods
Study Design
Longitudinal data collection, including psychosocial and sexual
behavioral data, was nested within the randomized, 24-month
open-label STRATALL ANRS 12110/ESTHER trial (Clinical-
Trials.gov, NCT00301561) in Cameroon, designed to compare the
effectiveness of clinical monitoring (n=238 patients) versus clinical
plus laboratory monitoring (viral load plus CD4) [11] (n=221pa-
tients). The detailed methodology and main results of the
STRATALL trial have already been reported elsewhere [12].
Briefly, 459 ART-naı ¨ve patients were enrolled between May 23,
2006 and January 31, 2008 in nine rural district hospitals located in
theCentreProvinceand followed-upover2 years.Eligibilitycriteria
included having a HIV-1 group M infection, being older than 18
years and being eligible for ART, in accordance with national
guidelines and WHO 2006 recommendations [13]. Participants
were requested to attend clinical visits which included an interview
and a physical examination by a healthcare professional at weeks 0
and 2, months 1 and 3, and every 3 months thereafter.
Socio-economic, psychosocial and behavioural data were
collected after the clinical visit at baseline (M0, i.e., date of
treatment initiation), and at months 6 and 12, using face-to-face
questionnaires administered by community health workers trained
by the research team. During face-to-face interviews, patients were
asked a series of questions including information about sexual
activity and adherence to treatment. Patients also received
counseling on ART-adherence and prevention of HIV transmis-
sion when initiating ART and at each follow-up visit. Condoms
were provided for free in the hospitals’ pharmacies.
Clinical data collected for the purpose of the trial, including
HIV clinical stages and CD4 cell count (assessed by Facscount
equipment), were also used in this analysis.
The study protocol was approved by the National Ethics
Committee of Cameroon and the institutional Ethics Committee
of the Institut de Recherche pour le De ´veloppement (France) and all study
participants provided written informed consent.
Definition of Inconsistent Condom Use (ICU)
Use of condoms during the previous three months was assessed
separately for the main partner and for casual partners using a
four-level scale: never, sometimes, nearly always or always [14].
Inconsistent condom use (ICU) was defined at each follow-up visit
as reporting to have ‘‘never’’, ‘‘sometimes’’ or ‘‘nearly always’’
used condoms with one’s main or casual partner(s) - either HIV
negative or of unknown HIV status in the three previous months.
As information about HIV-status (HIV-positive, HIV-negative
or unknown) was only available for the main partner, all casual
partners were considered to have unknown HIV status.
Variables
Variables retained for the analyses were classified into the
following five categories:
– socio-demographic and economic characteristics: gender, age,
educational level, professional status, marital status, place of
religion in one’s life and perceived social class. They were
assessed using a ten-point visual scale, with higher scores
denoting a better perceived social situation (higher income,
higher educational level and better job) [15].
– clinical characteristics: WHO clinical stage and CD4 cell
count.
– sexual behavior and reproductive life during the previous three
months: number of sexual partners including casual partners,
frequency of sexual intercourse, type of sexual partner(s) (main
only; casual only, main and casual), condom use, having
children and the desire for a/another child.
– caregiver-patients relationships: feeling comfortable with doc-
tors (very comfortable, quite comfortable, not very comfortable
and not at all comfortable), trust in doctors and trust in other
healthcare staff using a three-point Likert scale (no trust, little
trust and complete trust) and healthcare staff’s readiness to
listen, assessed using a six-point visual scale ranging from 1 to 6
with higher values denoting a higher perceived degree of
readiness to listen.
– psychosocial variables: adherence to ART, satisfaction about
information provided by care staff, binge drinking, experience
of discrimination and depressive symptoms.
Adherence to ART was assessed using a validated scale [16]
including 13 questions. Patients were asked to list, for each
antiretroviral drug, the daily number of prescribed pills they had
taken during the 4 days prior to the visit. They were also asked if
they had ‘‘totally’’ or ‘‘partially’’ taken their prescribed doses of
ART or had ‘‘interrupted their treatment for more than two
consecutive days’’ during the 4 previous weeks. Those who
reported taking 100% of their prescribed doses in the 4 days before
the visit and ‘‘had not interrupted their treatment’’ even once for
more than two consecutive days during the 4 previous weeks were
classified as ‘‘adherent’’ while those who reported taking less than
100% of their prescribed doses in the previous 4-day period or had
‘partially’ taken their prescribed doses or ‘‘interrupted their
treatment’’ at least once for more than two consecutive days
during the 4 previous weeks were classified as ‘‘non- adherent’’.
Data on adherence reported during clinical visits 28 days before
and 7 days after each face-to-face questionnaire visit were also
used to increase the sensitivity of the score to detect non-adherence
behaviors. Patients who were classified as adherent using the face-
to-face questionnaires but whose clinical data indicated that they
had taken less than 100% of their prescribed drug doses during the
previous 7 days of the clinical visit were classified as non-adherent.
The self-reported measure of adherence was validated using a
logistic regression model based on the generalized estimating
equation, where the outcome was HIV viral load (undetectable vs.
detectable) and the explanatory variable was the self-reported
measure of adherence (adherent versus non-adherent). The results
showed a significant association between non-adherence and
ART Adherence and Sexual Risk Behaviors
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p=0.001).
To assess patient satisfaction about information provided by
healthcare staff, two variables were used: 1) readiness to listen of
healthcare staff and 2) perceived quality of information provided
by healthcare staff assessed using a four-point Likert scale (clear
information, quite clear information, unclear information and no
information at all).
Finally, patients who reported high healthcare staff’s readiness
to listen and reported to have received clear or quite clear
information were considered as ‘‘satisfied about information
provided by care staff’’.
Binge drinking was defined as the consumption of three large
bottles (two liters with 5,2 milliliters of alcohol per 100 ml) and/or
six glasses or more of alcoholic beverages on any one occasion
[14]. Depressive symptoms were assessed using the Center for
Epidemiologic Studies Depression Scale (CES-D) [17], which
enables a global depression score to be calculated, ranging from 0
to 60, with higher values denoting more depressive symptoms.
Statistical Analysis
We first estimated the global proportion of ICU during the first
12 months of ART and the frequency of ICU at each visit. The
proportion of ICU over a given period was calculated as the
number of visits at which the study population reported ICU over
the number of visits performed. Mixed-effect logistic regression
models - which enable the correlations between repeated measures
to be taken into account - were used to estimate the relationship
between adherence and sexual risk behaviors. As the proportion of
patients reporting ICU during the first 12 months of ART was not
significantly different between the two treatment approaches (i.e.,
clinical monitoring versus clinical plus laboratory monitoring)
when performing a chi-square test (p-value=0.20), both groups
were pooled in analysis. All explanatory variables with a P-value
,0.20 in the univariate analyses were eligible to enter the initial
multivariate model. The final multivariate model was obtained by
using a backward stepwise procedure based on the log-likelihood
ratio to eliminate non-significant (P.0.05) variables from the
initial model.
Statistical analyses were performed using SPSS v15.0 (SPSS,
Inc., Chicago, Illinois, USA) and Intercooled Stata 10 (StataCorp
LP, College Station, Texas, USA) software packages.
Results
Characteristics of HIV Patients
All 459 PLWHA who initiated ART in the Stratall ANRS
12110/ESTHER trial agreed to participate in the socio-behav-
ioral study. During the first 12 months of ART, data on sexual
behaviors were available for 435 patients (95%). Among them, 308
(71%) were women, median [interquartile range, IQR] age was 36
years (30–45), 101 (23%) reported being married and 213 (49%)
patients had an educational level higher than secondary school.
Patients who had no data on sexual behaviors (n=24) were not
significantly different compared with those for whom data were
available in terms of gender, age and CD4 cell count at ART
initiation (data available on request). Among patients having data
on sexual behaviors, 241 (55%) reported sexual activity at least
once during all follow-up visits while 194 (45%) reported sexual
abstinence during the first 12 months of ART. Those patients who
reported sexual activity were younger than their sexually abstinent
counterparts (median [IQR]=35 years [30–42] versus 39 years
[31–47], P,10
23 (test de Mann-Whitney)); they were more
frequently married, reported more often the desire to have a/
another child, and had a higher median CD4 cell count. No
significant differences were however detected concerning gender
and WHO clinical stage.
Study Population
Among the 241 respondents who reported to have been sexually
active during the first 12 months of follow up, 29 (12%) declared
that they had sex only with HIV positive partner(s). We therefore
conducted our analysis on the remaining 212 (88%) patients (i.e.,
accounting for 344 visits) who reported at least once to have had
sexual intercourse during the first 12 months of treatment with
their main or casual partner(s) - either HIV-negative or of
unknown HIV status. Among these 212 patients, 153 (72%) -
accounting for 212 visits (62%) - reported inconsistent condom
use.
Baseline Characteristics of the Study Population (n=212)
The median age [IQR] of patients was 35 [29–43] and more
than a third (69%) were women. A quarter (25%) were married
and approximately half (51%) reported having a professional
activity. Regarding HIV-related characteristics, a quarter (26%) of
patients were at WHO clinical stage IV, the overall median [IQR]
CD4 cell count per mm
3 was 200 [82–393] and the median [IQR]
score of depressive symptoms was 22 [15–29]. Concerning sexual
behaviors and reproductive life characteristics, 53% of patients
declared to be sexually active at baseline (31% had only a main
partner, 12% had at least one casual partner, 10% had both main
and casual partner(s) while 47% had no partner). A quarter of
patients who had a partner reported more than one sexual act per
week. The majority of patients (81%) had at least one child and
12% desired to have a/another child. Baseline characteristics of
the study population, stratified by sex, are presented in Table 1.
ICU and Adherence Trends
Of the total 344 visits corresponding to 212 HIV-patients who
reported at least once that they had sex during the first 12 months
of treatment with main or casual partner(s) - either HIV-negative
or of unknown HIV status (study population), 113 (32%), 112
(33%) and 119 (35%) were visits at enrollment (M0), M6 and M12
respectively. During follow-up, ICU was reported in 212 visits
(corresponding to 153 patients), broken down as follows: 86/113
visits (i.e. 76% of visits) at M0, 56/112 (50%) at M6 and 70/119
(59%) at M12 respectively. Adherence to ART was reported at
67/112 visits (i.e. 60% of visits) at M6 and at 79/119 (66%) at
M12. The proportion of ICU at visits where adherence to ART
was reported was 45% (30/67) at M6 and 57% (45/79) at M12
versus 58% (26/45) at M6 and 63% (25/40) at M12 at visits where
non-adherence was reported. To test whether the relationship
between non-adherence and ICU could change over time, we
tested the interaction between time and adherence over the period
M6–M12. It was not significant, confirming that this relationship
did not indeed change over time.
Factors Associated with ICU
In univariate analysis (Table 2), several socio-economic and
psychosocial characteristics were found to be significantly associ-
ated with a higher risk of ICU as follows: being married,
perceiving one’s social level as low, being professionally inactive
and having depressive symptoms. Conversely, none of the clinical
characteristics was significantly associated with ICU. Among
caregiver-patient relationship variables, high score for healthcare
staff’s readiness to listen, having trust in healthcare staff and being
satisfied about information provided by healthcare staff were all
ART Adherence and Sexual Risk Behaviors
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behavioral characteristics significantly associated with ICU
included the desire to have a child, having sex more than once
a week, having more than one sexual partner, having sex only with
casual partner(s) and having sex with both one’s main and casual
partner(s) (compared with one’s main partner only). Finally, both
adherence and non-adherence to ART were significantly associ-
ated with a reduced risk of ICU compared with baseline (i.e., at
ART initiation).
After adjustment in multivariate analysis for the frequency of
sexual acts, type of sexual partner (i.e., having a main partner only,
casual partner(s) only or having both a main and casual partners),
perceived social class and desire for a child, adherence to ART was
independently associated with a lower risk of ICU compared with
baseline (AOR [95% CI]=0.38 [0.19–0.76]; P=0.006) (Table 2).
In order to test whether satisfaction about the information
provided by healthcare staff (which has been found to be related
to adherence [18]) was on the same causal path leading to ICU,
we entered it in the final model instead of adherence. This variable
remained significantly associated with ICU (p,0.03). However,
when then adding adherence in the model, this variable was no
longer significant. To verify whether any factors could have had a
different impact on the outcome because of gender, we tested all
interactions between gender and eligible risk factors for ICU but
none was significant in the final model.
Discussion
In this population of Cameroonian HIV-infected adults
followed up in nine rural district hospitals, we documented a
reduction in ICU during the first year of follow-up after ART
initiation. This is consistent with the results of meta-analyses
conducted both in high and low-resource settings [7,8]. The
present study also highlights the fact that after adjustment for
known correlates of ICU, patients who were adherent after
commencing ART were less likely to report ICU than before
commencing it. However the increase in ICU observed in ART
adherent patients from M6 to M12 (though not significant) is
consistent with previous research (outlined below), showing that
continued adherence to ART in the long term can lead to
increased risk behaviors as a result of improved health and beliefs
about reduced infectiousness [19].
In terms of PLWHA sexual behaviors, the impact of ART
initiation has been studied in several longitudinal studies in Sub-
Saharan Africa settings. A decline in the proportion of sexual risk
behaviors 6 months after ART initiation has been highlighted in
Uganda and South Africa [9,20]. Similar results were also
observed in Kenya after 12 months of treatment [21] and in
South Africa after 8 years [9]. Among all the available studies, only
a longitudinal study carried out by Diabate et al. in the Co ˆte
d’Ivoire showed an increase in the frequency of sexual risk
behaviors among PLWHA after six months of follow-up [22]. Few
longitudinal studies have however examined the relationships
between initiating ART, ART adherence and sexual risk behaviors
among HIV-infected Sub-Saharan African adults. In the present
study, we distinguished two sub-groups among patients after ART
initiation: those who were ‘‘adherent’’ to ART and those who were
‘‘non-adherent’’. Our study suggests that, after multiple adjust-
ment, ART-adherent patients were less likely to report sexual risk
behaviors while non-adherent patients had a similar risk to that
reported at baseline. This may suggest that patients who were
adherent to ART were also ‘‘adherent’’ to HIV prevention
messages provided during counseling sessions [6]. Sustained
adherence to ART is considered to be one major condition for
Treatment as Prevention (TasP) strategy [4] because it makes it
possible to both control HIV viral load and reduce the likelihood
of HIV transmission through sexual intercourse. However, the fact
that satisfaction about the information provided by healthcare staff
was associated with ICU when removing the adherence variable
from the final multivariate model - but not when both were
present in the model - confirms two things: first, that dissatisfaction
with the information provided by healthcare staff is a predictor of
ICU and second, that it constitutes an important component of
adherence behaviors [18]. As adherence behaviors are not only
determined by the quality of care delivered but also by factors
which are external to the healthcare system, like stigma and
disclosure [6,23], we can assume that those factors probably also
affect sexual behaviors.
Furthermore, the study’s findings show that participants who
desired to have children were more likely to report inconsistent
Table 1. Baseline characteristics of HIV-infected patients reporting sex with main or casual partner(s) - either HIV negative or
unknown status during the first year of antiretroviral therapy in Cameroon (n=212).
Women (n (%)
or median [IQR*])
(n=147)
Men (n (%)
or median [IQR*])
(n=65) p-value
Age (years) 40 [33–45] 33 [28–40] ,10
23
Educational level .primary school 76/144 (53) 36/59 (61) 0.28
Professionally inactive 66/135 (49) 20/60 (33) 0.04
Married 24/147 (16) 28/65 (43) ,10
23
Having children 109/140 (78) 62/65 (95) 0.001
Perceiving one’s social class as low 52/144 (36) 18/63 (29) 0.29
Sexually active 65/140 (46) 26/60 (43) 0.69
.1 partner 11/140 (8) 13/60 (22) 0.01
Desire to have another child 20/140 (14) 6/64 (9) 0.38
Binge drinking 16/137 (12) 16/60 (27) 0.01
Depressive symptoms 22 [16–29] 23 [15–28] 0.95
*IQR: interquartile range.
doi:10.1371/journal.pone.0036118.t001
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partner(s) - either HIV negative or of unknown status during the first year of antiretroviral therapy in Cameroon: univariate and
multivariate analyses using mixed-effect logistic models (212 patients, 344 visits).
Number of visits (%) or
median[IQR]
Number of
patients OR [95%CI] p-value AOR [95%CI]p-value
Socio-demographic and economic characteristics
Female gender 240 (70) 147 1.10 [0.52–2.31] 0.81
Age – OR per 10-year increase 35 [30–43] 1.21 [0.83–1.78] 0.32
Educational level .primary school* 183 (53) 112 0.62 [0.31–1.23] 0.17
Professionally inactive* 128(37) 85 2.33 [1.14–4.76] 0.02
Married * 83 (24) 53 3.04 [1.24–7.45] 0.01
Perceiving one’s social class as low
c * 69 (31) 53 2.59 [1.28–5.23] 0.01 2.15 [1.05–
4.30]
0.03
Perceiving the place of religion in one’s life as very
important
189 (55) 117 0.67 [0.34–1.34] 0.26
HIV-related characteristics
WHO clinical stage IV 87 (25) 55 1.22 [0.55–2.67] 0.50
Baseline CD4 count – OR for a 100 cells/mm3 increase210 [82–407] 1.03 [0.89–1.20] 0.67
Baseline CD4 count ,200 cells/mm3 167 (49) 107 0.74 [0.38–1.48] 0.88
Sexual behaviors and reproductive live characteristics
More than one sexual act per week* 50 (15) 45 5.72 [2.03–
16.10]
0.004 4.31 [1.36–
13.67]
0.02
More than one sexual partner * 51 (15) 45 3.32 [1.29–8.52] 0.01
Having (a) casual partner(s)a* 91 (26) 74 4.92 [2.28–
10.85]
,10
23
Type of sexual partner(s)*
- Having main partner only (ref) 246 (73) 166 1.00 1.00
- Having casual partner(s) only 46 (14) 40 4.18 [1.54–
11.35]
0.005 3.73 [1.34–
10.35]
0.01
- Having main and casual partners 44 (13) 39 5.64 [1.94–
16.43]
0.002 4.96 [1.77–
13.89]
0.002
Having children 280 (81) 176 1.54 [0.64–3.75] 0.34
Desire to have a/another child*
-Y e s 66 (20) 53 3.30 [1.34–8.14] 0.01 3.25 [1.38–
7.64]
0.007
- No (ref) 247 (73) 170 1.00 1.00
- Unable to procreate 25 (7) 21 1.39 [0.42–4.65] 0.59 1.56 [0.50–
4.87]
0.45
Caregivers-patients relationship related characteristics
Feels very comfortable with doctors 243 (71) 158 0.90 [0.43–1.88] 0.78
High healthcare staff’s readiness to listen* 219 (64) 150 0.41 [0.19–0.86] 0.02
High trust in doctors (complete trust) 304 (88) 192 0.74 [0.19–2.91] 0.67
High trust in health care staff (complete trust)* 294 (85) 188 3.16 [1.04–9.58] 0.04
Psychosocial characteristics
ART treatment and adherence*
- Baseline (treatment not yet initiated) (ref) 113 (33) 113 1.00 1.00
- Treated and non-adherent 85 (25) 78 0.43 [0.20–0.92] 0.03 0.58 [0.26–
1.29]
0.19
- Treated and adherent 146 (42) 115 0.30 [0.15–0.58] ,10
23 0.38 [0.19–
0.76]
0.006
Satisfied about information provided by care staff* 220 (64) 150 0.49 [0.25–0.95] 0.04
ART Adherence and Sexual Risk Behaviors
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the proportion of patients who desired to have children from 14%
at M0 to 25% and 20% at M6 and M12 respectively. This suggests
that ART has a positive effect on the desire for children among
ART-treated PLWHA [25] but may therefore encourage unpro-
tected sex. In addition, motherhood is such a fundamental social
value in Africa that women’s desire for children may be stronger
than the fear of mother-to-child HIV transmission [26]. Our
results may also be considered in parallel with those from a study
recently conducted in Sub-Saharan Africa which showed a higher
rate of pregnancy among couples with at least one partner
receiving ART compared with couples with no ART [27].
As previously found in other studies, the frequency of sexual
intercourse per week [28,29], the perceived social class as well as
the type of sexual partner [14] were also found to be associated
with unsafe sex in our study.
Despite these interesting results, some study limitations need to
be recognized. Sexual behaviors and adherence assessment are
based on self-reports which are known to be affected by social
desirability bias [20]. While this bias was better minimized in
terms of adherence by using a specific algorithm based on several
questions, this was not the case for inconsistent condom use. Bias
induced by face to face interviews was however reduced by
training counselors in the use of non-judgmental approaches.
Another limitation of the study is that we could not distinguish
whether or not sexual behaviors were different according to the
type of casual partners (e.g. sex-trade partners versus other
partners). Indeed, it is possible that condom use with sex-trade
partners was reported very differently than for any other type of
partnership. Despite this weakness, the proportion of reported
ICU was similar to that reported in other studies in Cameroon
[14]. Finally, as this study was part of a clinical trial focusing in
which patients who were unlikely to attend clinical visits were not
eligible might have reduced the relationship strength between
adherence to treatment and ICU. As in any trial, a problem of
external validity may be present, affecting the generalization of
these results in the operational research context. Hence it is
possible that the proportion of ART-adherent PLWHA may have
been higher than that which would have been obtained in an
operational context.
In conclusion, this study highlights that adherence to ART is
associated with a lower risk of ICU but this result needs to be
interpreted carefully. As adherence behaviors are not only
determined by problems with the healthcare systems but also by
social barriers encountered by patients in their daily life,
counseling should not only be ART adherence-centered but
patient-centered, including sexual risk minimization and psycho-
social support.
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